Related Experiment Videos

[Anticoagulation in patients with cardiac valve prostheses]

Domenico Paparella1, Chiara d'Agostino, Luigi de Luca Tupputi Schinosa

  • 1Istituto di Cardiochirurgia, Dipartimento d'Emergenza e Trapianti d'Organo, Università, Bari. paparella@tin.it

Recenti Progressi in Medicina
|May 19, 2004
PubMed

Insights

Patients with artificial heart valves need anticoagulation to prevent blood clots. This guide offers updated recommendations for anticoagulant therapy based on valve type and patient factors, including special situations like pregnancy.

Area of Science:

  • Cardiology
  • Hematology
  • Pharmacology

Context:

  • Patients with heart valve prostheses have an elevated risk of thromboembolic events.
  • Anticoagulation is frequently necessary post-heart valve replacement surgery.
  • Thromboembolic risk is influenced by prosthesis design, patient factors, and anticoagulation effectiveness.

Purpose:

  • To review current understanding of thrombus formation pathophysiology.
  • To discuss pharmacological properties of common anticoagulants.
  • To provide evidence-based suggestions for anticoagulation regimens.

Summary:

  • Discusses advances in understanding thrombus formation and anticoagulant pharmacology.
  • Offers tailored anticoagulation strategies based on randomized clinical trials, considering prosthesis type, implant site, and patient characteristics.
  • Highlights management of complex scenarios like pregnancy and major hemorrhage requiring anticoagulation interruption.

Impact:

  • Aims to optimize anticoagulation management in patients with heart valve prostheses.
  • Provides guidance for clinicians to reduce thromboembolic events and manage bleeding risks.
  • Contributes to improved patient outcomes following heart valve replacement.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...